A. M. Dąbrowska, “Could osteoprotegerin serve as a marker of metabolic syndrome?”, Curr. Issues Pharm. Med. Sci., vol. 26, no. 3, pp. 309–312, Sep. 2013, doi: 10.12923/j.2084-980X/26.3/a.15.